0001803599FALSE00018035992026-04-292026-04-29

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): April 29, 2026
CONCENTRIX CORPORATION
(Exact name of registrant as specified in its charter)

Delaware001-3949427-1605762
(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification Number)

39899 Balentine Drive, Suite 235, Newark, California
94560
(Address of principal executive offices)(Zip Code)

(800) 747-0583
(Registrant’s telephone number, including area code)

N/A
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))



Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.0001 per shareCNXCThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company   ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐



Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Under the terms of the Investor Rights Agreement, dated as of March 29, 2023 (the “Investor Rights Agreement”), by and among Concentrix Corporation (the “Company”) and certain former stockholders of Marnix Lux SA, a public limited liability company (société anonyme) incorporated under the laws of the Grand Duchy of Luxembourg and the former parent company of the Webhelp business, Groupe Bruxelles Lambert SA, a public limited liability company (société anonyme) incorporated under the laws of Belgium (together with its affiliates, “GBL”) had the right to nominate one director to the Company’s Board of Directors (the “Board”) for so long as GBL beneficially owned at least 50% of the shares of the Company’s common stock issued to GBL in connection with the Company’s September 2023 acquisition of the Webhelp business (such ownership threshold, the “Board Nomination Threshold”).
On April 29, 2026, GBL entered into a transaction that reduced its beneficial ownership of the Company’s common stock below the Board Nomination Threshold. As a result, pursuant to the terms of the Investor Rights Agreement, Bilge Ogut resigned from the Board, including any committees thereof, effective immediately.

Item 9.01    Financial Statements and Exhibits.
Exhibit No.Description
104Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 1, 2026
CONCENTRIX CORPORATION
  
 By:/s/ Jane C. Fogarty
 
Jane C. Fogarty
Executive Vice President, Legal